Listed

Nutex Health Inc.: Form 10-Q/A for the period ended Jun 30, 2020

Filed with the SEC on Aug 24, 2020 and accepted by EDGAR at Aug 21, 2020, 21:06 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-01 to 2020-06-30$378.6kus-gaap:Revenues
Revenue6 months2020-01-01 to 2020-06-30$844.2kus-gaap:Revenues
Cost of revenue3 months2020-04-01 to 2020-06-30$264.9kus-gaap:CostOfRevenue
Cost of revenue6 months2020-01-01 to 2020-06-30$464.0kus-gaap:CostOfRevenue
Gross profit3 months2020-04-01 to 2020-06-30$113.7kus-gaap:GrossProfit
Gross profit6 months2020-01-01 to 2020-06-30$380.2kus-gaap:GrossProfit
Research and development3 months2020-04-01 to 2020-06-30$314.3kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2020-01-01 to 2020-06-30$429.1kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2020-04-01 to 2020-06-30−$1.7mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-30−$2.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-04-01 to 2020-06-30$249.3kus-gaap:InterestExpense
Interest expense6 months2020-01-01 to 2020-06-30$314.3kus-gaap:InterestExpense
Net income3 months2020-04-01 to 2020-06-30$2.8mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30$1.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-04-01 to 2020-06-30$0.59us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2020-01-01 to 2020-06-30$0.35us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2020-01-01 to 2020-06-30−$1.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-30$0us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-06-30$63.6kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-30$365.0kus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$7.2mus-gaap:Assets
Current liabilitiesAt period end2020-06-30$1.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-06-30$1.4mus-gaap:Liabilities
Long-term debtAt period end2020-06-30$0us-gaap:LongTermDebt
Shareholders' equityAt period end2020-06-30$5.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001607062-20-000246. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.